Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
14.40
+0.35 (2.49%)
Nov 20, 2024, 4:00 PM EST - Market closed

Prothena Corporation Revenue

Prothena Corporation had revenue of $970.00K in the quarter ending September 30, 2024, a decrease of -98.86%. This brings the company's revenue in the last twelve months to $133.35M, down -5.41% year-over-year. In the year 2023, Prothena Corporation had annual revenue of $91.37M with 69.50% growth.

Revenue (ttm)
$133.35M
Revenue Growth
-5.41%
P/S Ratio
5.80
Revenue / Employee
$770,809
Employees
173
Market Cap
774.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020853.00K39.00K4.79%
Dec 31, 2019814.00K-141.00K-14.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Avanos Medical 681.50M
Castle Biosciences 311.88M
Cronos Group 111.23M
AbCellera Biologics 32.96M
Autolus Therapeutics 10.09M
Relay Therapeutics 10.01M
Revenue Rankings